Everyone in the medical community vividly remembers the pandemic days when there was a shortage of personal protective equipment (PPE), leading to a global supply chain crisis. Similar to what we see in initiatives to improve flexibility in the pharmaceutical industry through the new EU strategy (see previous blog), we expect a similar effort in the companies that support and supply these industries.
Consider, for example, companies that produce sterile consumables, clothing, as well as raw materials. The problems they experienced during the pandemic were similar to those of the pharmaceutical industry, and again now, they will need to connect with the changes in the pharmaceutical sector. Preferably before another pandemic strikes.
